2-Hydroxy-4-glutathion-S-yl-17β-estradiol and 2-hydroxy-1-glutathion-S-yl-17β-estradiol produce oxidative stress and renal toxicity in an animal model of 17β-estradiol-mediated nephrocarcinogenicity

Carcinogenesis

Volumn 19, Issue 1, 1998, Pages 133-139

  Butterworth, Michael ^a,b   Lau, Serrine S ^a   Monks, Terrence J ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL ESTROGEN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; LIPID HYDROPEROXIDE; PROTEIN; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; INCIDENCE; KIDNEY CARCINOMA; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; SYRIAN HAMSTER;

ANIMALS; CARCINOGENS; CRICETINAE; EPITHELIAL CELLS; ESTRADIOL; GLUTATHIONE; KIDNEY; KIDNEY MEDULLA; KIDNEY NEOPLASMS; KIDNEY TUBULES, PROXIMAL; MALE; MESOCRICETUS; OXIDATIVE STRESS; SUPEROXIDES;

EID: 0031820170     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.1.133     Document Type: Article

References (83)

1. Huff, J., Boyd, J. and Barrett, J.C. (1996) Cellular and Molecular Mechanisms of Hormonal Carcinogenesis. Environmental Influences. Wiley-Liss, Inc., New York.
2. Matthews, V.S., Kirkman, H. and Bacon, R.L. (1947) Kidney damage in the golden hamster following chronic administration of diethylstilbestrol and sesame oil. Proc. Soc. Expt. Biol. Med., 66, 195-196.
3. Kirkman, H. and Bacon, R.L. (1952) Estrogen-induced tumors of the kidney. 1 - Incidence of renal tumors in intact and gonadectomized male golden hamster treated with diethystilbestrol. J. Natl Cancer Inst., 13, 745-755.
4. Kirkman, H. (1959) Estrogen-induced tumors of the kidney III. Growth characteristics in the Syrian hamster. Natl Cancer Inst. Monogr., 1, 1-57.
5. Li, J.J. and Li, S.A. (1987) Estrogen carcinogenesis in hamster tissues: role of metabolism. Fed. Proc., 46, 1858-1863.
6. Li, J.J. and Li, S.A. (1990) Estrogen carcinogenesis in hamster tissues: A critical review. Endocrine Rev., 11, 524-531.
7. Zhu, B.Q., Roy, D. and Liehr, J.G. (1993) The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites. Endocrinology, 132, 577-583.
8. Li, J.J., Li, S.A., Oberley, T.D. and Parsons, J.A. (1995) Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation. Cancer Res., 55, 4347-4351.
9. Yang, N.N., Venugopolan, M., Hardikar, S. and Glasebrook, A. (1996) Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science, 273, 1222-1225.
10. Monks, T.J., Hanzlik, R.P., Cohen, G.M., Ross, D. and Graham, D.G. (1992) Contemporary issues in toxicology. Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol., 112, 2-16.
11. Ketterer, B. and Mulder, G.J. (1990) Glutathione conjugation. In Mulder, G.J. (ed.) Conjugation Reactions in Drug Metabolism. Taylor and Francis, London, pp. 307-364.
12. Monks, T.J., Anders, M.W., Dekant, W., Stevens, J.L., Lau, S.S. and van Bladeren, P.J. (1990) Contemporary issues in toxicology. Glutathione conjugate mediated toxicities. Toxicol. Appl. Pharmacol., 106, 1-19.
13. Monks, T.J. and Lau, S.S. (1992) Toxicology of quinone-thioethers. Crit. Rev. Toxicol., 22, 243-270.
14. Monks, T.J. and Lau, S.S. (1994) Glutathione conjugation as a mechanism for the transport of reactive metabolites. In Anders, M.W. and Dekant, W. (eds) Advances in Pharmacology, Vol. 27: Conjugation-Dependent Carcinogenicity and Toxicology of Foreign Compounds. Academic Press, New York, pp. 183-210.
15. Monks, T.J. and Lau, S.S. (1994) Glutathione conjugate mediated toxicities. In Kauffman, F.C. (ed.) Handbook of Experimental Pharmacology, Vol. 112: Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity. Springer Verlag, Berlin, pp. 459-509.
16. Marks, F. and Hecker, E. (1969) Metabolism and mechanism of action of estrogens. XII. Structure and mechanism of formation of water-soluble and protein-bound metabolites of estrone in rat liver microsomes in vitro and in vivo. Biochim. Biophys. Acta, 187, 250-265.
17. Kuss, E. Water-soluble metabolites of oestradiol-17β. (1969) Separation and identification of 1-and 4-glutathione thioethers of 2,3-dihydroxy-oestratrienes. Hoppe-Seyler's Z. Physiol. Chem., 350, 95-97.
18. Kuss, E. (1971) Microsomal oxidation of estradiol-17β. 2-Hydroxylation and 1-or 4-thioether formation with and without 17-hydroxyl dehydrogenation. Hoppe-Seyler's Z. Physiol. Chem., 352, 817-836.
19. Hoppen, H.-O., Siekmann, L. and Breuer, H. (1974) Metabolism of oestrone in the microsomal fraction of rat liver. Hoppe-Seyler's Z. Physiol. Chem., 355, 1305-1315.
20. Elce, J.S. (1970) Metabolism of a glutathione conjugate of 2-hydroxyestradiol by rat liver and kidney preparations in vitro. Biochem J., 116, 913-917.
21. Elce, J.S. (1972) Metabolism of a glutathione conjugate of 2-hydroxyestradiol-17β in the adult male rat. Biochem J., 126, 1067-1071.
22. Elce, J.S. and Harris, J. (1971) Conjugation of 2-hydroxy-estradiol-17β [1,3,5(10)-estratriene-2,3,17β-triol] with glutathione in the rat. Steroids, 18, 583-591.
23. Elce, J.S., Bird, C.E. and Chandra, J. (1973) Water soluble products of the estrogens. Bile metabolites of 2-hydroxyestradiol-17β in man. J.Clin. Endocrinol. Metab., 36, 1027-1030.
24. Ball, P., Haupt, M. and Knuppen, R. (1983) Biogenesis and metabolism of catechol estrogens in vitro. In Merriam, G.R. and Lipsett, M.B. (eds) Catechol Estrogens. Raven Press, New York, pp. 91-103.
25. Iverson, S.L., Shen, L., Anlar, N. and Bolton, J.L. (1996) Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem. Res. Toxicol., 9, 492-499.
26. Butterworth, M., Lau, S.S. and Monks, T.J. (1996) 17β-Estradiol metabolism in hamster liver microsomes. Implications for the catechol O-methyltransferase mediated detoxication of catechol estrogens. Drug Metab. Disp., 24, 588-594.
27. Butterworth, M., Lau, S.S. and Monks, T.J (1996) 17β-Estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation. Chem. Res. Toxicol., 9, 793-799.
28. Butterworth, M., Lau, S.S. and Monks, T.J. (1997) Formation of catechol estrogen glutathione conjugates and γ-glutamyl transpeptidase-dependent nephrotoxicity of 17β-estradiol in the golden Syrian hamster. Carcinogenesis, 18, 561-567.
29. Kuthan, H., Ullrich, V. and Estabrook, R.W. (1982) A quantitative test for superoxide radicals produced in biological systems. Biochem. J., 203, 551-558.
30. Li, J.J., Li, S.A., Klicka, J.K., Parsons, J.A. and Lam, L.K.T. (1983) Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res., 43, 5200-5204.
31. Habig, W.H., Pabst, M.J. and Jakoby, W.B. (1974) Glutathione-S-transferase, the first step in mercapturic acid formation. J. Biol. Chem., 249, 7130-7139.
32. Buege, J.A and Aust, S.D. (1978) Microsomal lipid peroxidation. Methods Enzymol., 52, 302-310.
33. Pryor, W.A. and Castle, L. (1984) Chemical methods for the detection of lipid hydroperoxides. Methods Enzymol., 103, 293-299.
34. Oliver, C.N., Ahn, B.W., Moerman, E.J., Goldstein, S. and Stadtman, E.R. (1987) Age-related changes in oxidized proteins. J. Biol. Chem., 262, 55488-55491.
35. Hsu, S., Raine, L. and Fanger, H. (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580.
36. Wicoxon, F. (1945) Individual comparisons by ranking methods. Biometrics Bull., 1, 80-83.
37. Mann, H.B. and Whitney, D.R. (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Statist., 18, 50-60.
38. Monks, T.J., Lau, S.S., Highet, R.J. and Gillette, J.R. (1985) Glutathione conjugates of 2-bromohydroquinone are nephrotoxic. Drug Metab. Dispos., 13, 533-559.
39. Monks, T.J., Highet, R.J. and Lau, S.S. (1988) 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical and electrochemical determinants. Molec. Pharmacol., 34, 492-500.
40. Lau, S.S., Hill, B.A., Highet, R.J. and Monks, T.J. (1988) Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. Molec. Pharmacol., 34, 829-836.
41. Monks, T.J. and Lau, S.S. (1990) Glutathione conjugation, γ-glutamyl transpeptidase and the mercapturic acid pathway as modulators of 2-bromohydroquinone oxidation. Toxicol. Appl. Pharmacol., 103, 557-563.
42. Li, J.J., Gonzalez, A., Banerjee, S., Banerjee, S.K. and Li,S.A. (1993) Estrogen carcinogenicity in hamster kidney: Role of cytotoxicity and cell proliferation. Environ. Hlth Perspect., 101, 259-264.
43. Gonzalez, A., Oberley, T.O. and Li, J.J. (1989) Morphological and immunohistochemical studies of the estrogen-induced Syrian hamster renal tumor: Probable cell of origin. Cancer Res., 49, 1020-1028.
44. deKernion, J.B. (1986) Renal tumors. In Walsh, P.C., Gittes, R.F. Perlmutter, A.D. and Stanlet, T.A (eds) Campbell's Urology, 5th edn. Saunders, Philadelphia, pp. 1294-1342.
45. Tannenbaum, M. (1971) Ultrastructural pathology of human renal cell tumors. Pathol. Ann., 6, 249-277.
46. Vorherr, H. (1974) The Breast. Morphology, Physiology, and Lactation. Academic Press, New York.
47. Vina, J., Puertes, J.R., Montoro, J.B. and Vina, J.R. (1983) Effect of specific inhibition of γ-glutamyl transpeptidase on amino acid uptake by mammary gland of the lactating rat. FEBS Lett., 159, 119-122.
48. Baumrucker, C.R. (1985) Amino acid transport systems in bovine mammary tissue. J. Dairy Sci., 68, 2436-2451.
49. Miller, R.T., Lau, S.S. and Monks, T.J. (1997) 2.5-bis-(Glutathion-S-yl)-α-methyldopamine, a putative metabolite of (±)-3,4-methylene-dioxyamphetamine, produces long-term decreases in brain serotonin concentrations. Eur. J. Pharmacol., 323, 173-180.
50. Shibata, M.-A., Hirose, M., Tanaka, H., Asakawa, E., Shirai, T. and Ito, N. (1991) Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment. Jpn. J. Cancer Res., 82, 1211-1219.
51. 1 mice. Fd. Chem. Toxicol., 30, 737-747.
52. Hill, B.A., Kleiner, H.K., Ryan, E.A., Dulik, D.M., Monks, T.J. and Lau, S.S. (1993) Identification of multi-S-substituted conjugates of hydroquinone by HPLC-coulometric electrode array analysis and mass spectroscopy. Chem Res. Toxicol., 6, 459-469.
53. Rehwoldt, R. (1986) Tracking the use of antioxidants through industry surveys. Fd Chem. Toxicol., 24, 1039-1041.
54. Tsuda, H., Fukushima, S., Imaida, K., Sakata, T. and Ito, N. (1984) Modification of carcinogenesis by antioxidants and other compounds. Acta Pharmacol. Toxicol. Suppl. 2, 125-143.
55. Imaida, K., Fukushima, S., Shirai, T., Ohtani, M., Nakanishi, K. and Ito, N. (1983) Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of γ-glutamyl transpeptidase-positive foci development in the rat. Carcinogenesis, 4, 895-899.
56. Nera, E.A., Iverson, F., Lok, E., Armstrong, C.L., Karpinski, K. and Clayson, D.B. (1988) A carcinogenesis reversibility study of the effects of butylated hydroxyanisole on the forestomach and urinary bladder in male Fischer 344 rats. Toxicology, 53, 251-268.
57. Ito, N., Hirose, M., Fukushima, S., Tsuda, H., Shirai, T. and Tatematsu, M. (1986) Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis. Fd Chem. Toxicol., 24, 1071-1082.
58. Verhagen, H., Thijssen, H.H.W., Ten Hoor, F. and Kleinjans, J.C.S. (1989) Disposition of single oral doses of butylated hydroxyanisole in man and rat. Fd Chem. Toxicol., 27, 151-158.
59. Shibata, M.A., Asakawa, E., Hagiwara, A., Kurata, Y. and Fukushima, S. (1991) DNA synthesis and scanning electron microscopic lesions in renal pelvic epithelium of rats treated with bladder cancer promoters. Toxicol. Lett., 55, 263-272.
60. Tamano, S., Fukushima, S., Shirai, T., Hirose, M. and Ito, N. (1987) Modification by α-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Lett., 35, 39-46.
61. Fukushima, S., Shibata, M.A., Kurata, Y., Tamano, S. and Masui, T. (1986) Changes in the urine and scanning electron microscopically observed appearance of the rat bladder following treatment with tumor promoters. Jpn. J. Cancer Res., 77, 1074-1082.
62. Kurata, Y., Fukushima, S., Hasegawa, R., Hirose, M., Shibata, M.A., Shirai, T. and Ito, N. (1990) Structure-activity relations in promotion of rat urinary bladder carcinogenesis by phenolic antioxidants. Jpn. J. Cancer Res., 81, 754-759.
63. Peters, M.M., Lau, S.S., Dulik, D.M., Murphy, D., van Ommen, B., van Bladeren, P.J. and Monks, T.J. (1996) Metabolism of 1-tert-butylhydroquinone to 5-substituted conjugates in the male Fischer 344 rat. Chem. Res. Toxicol., 9, 133-139.
64. Peters, M.M., Jones, T.W., Monks, T.J. and Lau, S.S. (1996) Glutathione conjugates of 2-tert-butylhydroquinone, metabolites of the renal tumor promoter tert-butylhydroxyanisole, are toxic to kidney and bladder. Cancer Res., 56, 1006-1011.
65. Siegfried, J.M., Nekon, K.G., Martin, J.L. and Kaufman, D.G. (1984) Promotional effect of diethyl-stilbestrol on human endometrial stromal cells pretreated with a direct-acting carcinogen. Carcinogenesis, 5, 641-646.
66. Wanless, I.R. and Medline, A. (1982). Role of estrogens as promoters of hepatic neoplasia. Lab. Invest., 46, 313-320.
67. Rudiger, H.W., Haenisch, F., Metzler, M., Oesch, F. and Glatt, H.R. (1979). Metabolites of diethyl-stilbestrol induce sister chromatid exchange in human cultured fibroblasts. Nature, 281, 392-394.
68. Hill, A. and Wolff, S. (1983). Increased induction of sister chromatid exchange by diethylstilbestrol in lymphocytes from pregnant and premenopausal women. Cancer Res., 43, 4114-4118.
69. Tsutsui, T., Degen, G.H., Schiffmann, D., Wong, A., Maizumi, H., McLachlan, J.A. and Barrett, J.C. (1984). Dependence on exogenous metabolic activation for induction of unscheduled DNA synthesis in Syrian hamster embryo cells by diethylstilbestrol and related compounds. Cancer Res., 44, 184-189.
70. Tsutsui, T., Maizumi, H., McLachlan, J.A. and Barrett, J.C. (1983). Aneuploidy induction and cell transformation by diethylstilbestrol: a possible chromosomal mechanism in carcinogenesis. Cancer Res., 43, 3814-3821.
71. Liehr, J.D., Ulubelen, A.A. and Strobel, H.W. (1986) Cytochrome P-450-mediated redox cycling of estrogens. J. Biol Chem., 261, 16865-16870.
72. Kalyanaraman, B., Sealy, R. and Sivarajah, K. (1984) An electron spin resonance study of o-semiquinone formed during the enzymatic autoxidation of catechol estrogens. J. Biol. Chem., 259, 14018-14922.
73. Ross, D., Mehlhorn, R.J., Moldeus, P. and Smith, M.T. (1985) Metabolism of diethylstilbestrol by horseradish peroxidase and prostaglandin-H synthetase: generateion of free radical intermediates and its interaction with glutathione. J. Biol. Chem., 260, 16210-16214.
74. Liehr, J.G. (1990) Genotoxic effects of estrogens. Mutat. Res., 238, 269-276.
75. Wang, M.-Y. and Liehr, J.G. (1994) Identification of fatty acid hydroperoxide cofactors in the cytochrome P450-mediated oxidation of estrogens to quinone-metabolites. Role and balance of lipid peroxides during estrogen-induced carcinogenesis. J.Biol. Chem., 269, 284-291.
76. 3H]hydride reduction. J. Biol. Chem., 266, 14446-14450.
77. Burdon, R.D. (1995) Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Rad. Biol.Med., 4,775-794.
78. Lau, S.S., Peters, M.M., Kleiner, H.E., Canales, P.L. and Monks, T.J. (1996) Linking the metabolism of hydroquinone to its nephrotoxicity and nephrocarcinogenicity. In Snyder, R.R. et al. (eds) Biological Reactive Intermediates V. Basic Mechanistic Research in Toxicology and Human Health Risk Assessment. Plenum Press, New York, pp. 267-273.
79. Jeong, J.K., Stevens, J.L., Lau, S.S. and Monks, T.J. (1996) Quinone-thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells. Molec. Pharmacol., 50, 592-598.
80. Jeong, J.K., Huang, Q., Lau, S.S. and Monks, T.J. (1997) The response of renal epithelial cells to physiological-and chemical-induced growth arrest. J. Biol. Chem., 272, 7511-7518.
81. Jeong, J.K., Dybing, E., Søderlund, E., Brunborg, G., Holme, J.A., Lau, S.S. and Monks, T.J. (1997) DNA damage, gadd153 expression, and cytotoxicity in plateau phase renal proximal tubular epithelial cells treated with a quinol-thioether. Arch. Biochem. Biophys., 341, 300-308.
82. Lau, S.S., Kleiner, H.E. and Monks, T.J. (1995) Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone mediated nephrotoxicity. The role of N-acetylation and N-deacetylation. Drug Metab. Disp., 23, 1136-1142.
83. Lau, S.S., Jones, T.W., Sioco, R., Hill, B.A., Pinon, R.K. and Monks, T.J. (1990). Species differences in renal γ-glutamyl transpeptidase activity do not correlate with susceptibility to 2-bromo-(diglutathion-S-yl)hydroquinone mediated nephrotoxicity. Toxicology, 64, 291-311.